Biochemical and Objective Response to Abiraterone Acetate Withdrawal: Incidence and Clinical Relevance of a New Scenario for Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Biochemical and Objective Response to Abiraterone Acetate Withdrawal: Incidence and Clinical Relevance of a New Scenario for Castration-resistant Prostate Cancer

Published:2013-11 Issue:5 Volume:82 Page:1090-1093
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Caffo Orazio,Palermo Antonio,Veccia Antonello,Maines Francesca,Chierichetti Franca,Berruti Alfredo,Galligioni Enzo

Publisher

Elsevier BV

Subject

Urology

Reference27 articles.

1. The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors;Jarman;J Med Chem,1998

2. Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer;Attard;J Clin Oncol,2009

3. Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate;Reid;J Clin Oncol,2010

4. Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer;Danila;J Clin Oncol,2010

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high‐risk prostate cancer;IJU Case Reports;2023-07-21

2. PSA response to antiandrogen withdrawal: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2021-02-18

3. Factores predictivos del síndrome de retirada de abiraterona;Actas Urológicas Españolas;2019-07

4. Predictive factors for abiraterone withdrawal syndrome;Actas Urológicas Españolas (English Edition);2019-07

5. Metastatic prostate cancer remains incurable, why?;Asian Journal of Urology;2019-01